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Abstract 
 
Using microarray analysis, we showed up-regulation of  Toll-like receptors 
1,2,4,7,8, NF-, TNF-, p38-MAPK and MHC molecules in human peripheral blood 
mononuclear cells following infection with Plasmodium falciparum. We report herein 
further studies based on time-course microarray analysis with focus on malaria-induced 
host immunity.  Results show that in early malaria; selected immunity-related genes were 
up-regulated including and   interferon related genes, as well as genes of IL-15, 
CD36, chemokines (CXCL10, CCL2, S100A8/9, CXCL9, and CXCL11), TRAIL and 
IgG Fc receptors.  During acute febrile malaria, up-regulated genes included  and  
interferon related genes, IL-8, IL-1 IL-10 downstream genes, TGFB1, oncostatin-M, 
chemokines, IgG Fc receptors, ADCC signaling, complement-related genes, granzymes, 
NK cell killer/inhibitory receptors and Fas antigen.  During remission, genes for NK 
receptors, immunoglobins, and granzymes/perforin were up-regulated. When viewed in 
terms of immunity type, malaria infection appeared to induce a mixed TH1 response, in 
which α and β interferon driven responses appear to predominate over the more classic 
IL-12 driven  pathway.  In addition, TH17 pathway also appears playing a  significant 
role in the immunity to Plasmodium falciparum. Gene markers of TH17 (neutrophil-
related genes, TGFB1 and IL-6 family (oncostatin-M)) and TH (IFN- and NK  
cytotoxicity and ADCC gene ) immunity were up-regulated. Initiation of   immune 
response was associated with an IFN- response which ultimately resulted in  IFN-γ 
achieved via a pathway different from the more classic IL-12 TH1 pattern. Based on 
these observations, we speculate that in Plasmodium falciparum infection, T and 
TH17 immunity may predominate over more traditional TH1 response.   
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Introduction 
 
Host immunity may involve one or a combination of pathways. It has been 
suggested that TH1 immunity, initiated primarily by IL-12, may play an important 
immunological role in defense against viruses and intracellular bacteria/parasites, while 
TH2 responses, driven by IL4, have been shown to be more important against helminthes 
1. TH17 immunity is elicited against extracellular bacteria and this recently described 
host immunity pathway, is thought to be triggered by TGF-β working in tandem with IL-
21 or IL-6 2. Dendritic cells are important antigen processing cells and play an important 
role in stimulating both innate and adaptive immune responses to viruses, fungi and 
bacteria 3. In these cells, IL-12 is up-regulated following infection with E. coli and 
Candida albicans, but not influenza virus. In contrast, interferon alpha/beta is up-
regulated after infection with influenza virus, but not E. coli and Candida albicans. These 
observations suggest that IL-12 and IFN-αβ may help drive different immune response 
maturation pathways 3. It is not clear at this time as to which pathway may predominate 
in the host response to Plasmodium falciparum (P. falciparum) infection.  
 
TH1 has been suggested to be the dominant and protective immune response 
against malaria both in rodents and humans 4-5. Yet, the blood stage of P. falciparum can 
serve to immunosuppress the host’s immune response to the liver stage of the parasite 6. 
Dendritic cell maturation is inhibited by P. falciparum infected RBCs 7; monocyte 
maturation is also suppressed by malaria pigments (hemozoin), and low serum IL-12 was 
reported in severe malaria 8-9. These observations suggest that the IL-12 driven TH1 IFNg 
dominant response patterns seen following P. falciparum infection may not be 
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functioning optimally; thus, against this background data; one may ask how the infected 
host is capable of mounting an effective TH1 response against the blood-borne stage of 
this parasite? An alternative pathway may be needed to achieve this host immune 
response. 
 
To gain a better understanding of host immune response patterns associated P. 
falciparum infection in humans, we carried out transcriptional profiling using microarray 
analysis of peripheral blood mononuclear cells (PBMCs) after P. falciparum infection. 
Our earlier analysis showed an up-regulation of gene expression for Toll-like receptor 
signaling, NF-kB, TNF-, IFN-, IL-1, p38 MAPK, MHC class I & II molecules 10. In 
this study, we further analyzed the data focusing on the specific type or types of host 
immunity induced by infection. Results indicated an up-regulation of TGF-β and the IL-6 
family gene (oncostatin M), both of which induce TH17 immunity. We also observed an 
elevation in the expression of interferon gamma, NK cell cytotoxicity, antibody-
dependent cell cytotoxicity (ADCC), which are triggered by interferon alpha/beta 
(TH), instead of IL-12 (TH1). These results suggest multiple immune pathways may 
be activated following infection with P. falciparum.  For the purposed of this thesis we 
have classified these additional pathways as: TH and TH17 immunity. The THαβ 
pathway is not generally recognized within the immunology community as a distinct T 
cell maturation pathway while the TH17 response pattern has only recently been 
recognized 11.  However, THαβ responses in which α and β interferons drive a succession 
of cellular process leading to mid-moderate IFN-γ production and NK cell and ADCC 
activation have been described in the host response to viruses but they have not been 
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shown to play an important role in the maturation of the anti-malaria adaptive immune 
response. 
To further clarify this point, traditionally TH1 leads to immunity against intracellular 
bacteria and protozoa; and THαβ against viral infections. Macrophage activation is 
characteristic of traditional TH1 immunity, while NK activation (natural cytotoxicity & 
ADCC) is more characteristic of TH immunity. Thus, malaria infection appears to be 
somewhat unique in that it appears to elicit a combined response reflective of both TH17 
and THαβ host immunity.  
 
Material and Methods 
Previous analysis 
Subject recruitment, sample collection and preparation, and RNA purification 
were described previously in Ockenhouse and Hu’s paper. Briefly, two groups of subjects 
were recruited for this study after Johns Hopkins University Institutional Review Board 
and US Army HSRRB ethical approvals were obtained. In the study cohort, 22 subjects, 
20-45 years of age, were recruited from the Walter Reed Army Institute of Research 
(WRAIR).  Subjects agreed to receive mosquito bites from laboratory-reared Anopheles 
stephensi infected by P. falciparum (3D7 strain). Once parasitemia was detected in the 
subjects’s peripheral blood, these subjects received treatment with chloroquine. Blood 
samples were drawn during the un-infected baseline period (U) and again, when 
parasitemia was found for the first time (Early malaria) (E).  
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In the other study cohort, 15 adults were recruited from Cameroon, Africa. These 
subjects were 19-49 years of age with acute P. falciparum infection. All suffered from 
typical relapsing fever and blood smears showed parasitemia. These subjects received at 
least one week of anti-malarial drug treatment (Cotecxin). Blood drawing was performed 
during the acute febrile infection period (A) and one month later during the remission 
period (R). During the remission period, physical exams and blood smears were 
performed to ensure that malaria symptoms were no longer present and parasitemia was 
no longer detectable.  
 
In the first study cohort, PBMCs were separated from whole blood samples by 
Ficoll-gradient at WRAIR. In the second study cohort, blood was collected in CPT tubes 
and PBMCs were isolated after centrifuge. A RNA stabilizing reagent-RNA later 
(Ambion, CA, USA) was added and samples were shipped to the USA on dry ice. Total 
RNA was extracted from both sets of samples using Trizol. The quality of sample RNA 
was estimated by spectrometry (OD>1.8) and gel electrophoresis.  
 
Microarray preparation 
Affymetrix U133A GeneChips (Affymetrix, Santa Clara, CA) were used in this 
study. The GeneChips contain 22,283 probe-sets, including 14,500 known well-
characterized human genes and 18,400 transcripts. Before chip hybridization, a QIAGEN 
RNeasy cleanup kit was used to purify total RNA. Processing of templates for analysis on 
the Affymetrix U133A GeneChip was performed in accordance with methods described 
in the Affymetrix Technical Manual, Revision Three. Total RNA from the blood samples 
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were hybridized into the arrays. Detailed cDNA preparation, in vitro transcription, 
staining, and scanning of Affymetrix U133A GeneChips were described previously in 
Chris Ockenhouse and Wanchung Hu’s paper. 
 
Data analysis 
We used GeneSpring software and GeneSpring default normalization to perform 
one-way ANOVA tests, using un-infected samples as baseline. Significantly up-regulated 
genes were selected if false discovery rate (FDR) was <0.05 and fold change was >1.5x 
when compared to un-infected baseline. These genes were placed into three groups based 
on expression levels in different stages of the infection. In addition, Pearson’s correlation 
analysis and Rank correlation analysis were performed to find the relationship between 
expression levels of genes after malaria infection. Pathway analysis was performed by 
using the Pathway Architect (Statagene Inc.) software to identify the specific 
immunological pathways involved.  
 
Microarray accession numbers 
 The Affymetrix data sets can be accessed at http://www.ncbi.nlm.nih.gov/geo/ 
under the accession number GSE5418. 
 
Results 
A total of 2894 genes were differentially expressed out of the 22,283 probe sets in 
Affymetrix U133A GeneChip based on our criteria of data analysis. Gene expression 
patterns were measured in individuals with pre-symptomatic experimental early malarial 
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infection and in subjects with naturally-acquired acute febrile malarial infection. A 
baseline set of data derived from 22 uninfected healthy US subjects was used for gene 
comparison in samples from early malarial infection, acute febrile malarial infection, and 
remission stage. This baseline dataset is considered appropriate for comparisons between 
Cameroonian samples and USA samples because of the difficult in collecting baseline 
samples from Camerooian subjects that have had  no prior exposure to malaria.  As 
indicate previously, the study site in Cameroon is endemic for malaria so it is difficult to 
find adults in the area that may not already be in the prodromal phase of malaria. The 
correlation of the average gene expression of baseline samples to the average gene 
expression from 22 USA subjects and from 15 Cameroonian adults, exceeded 97% 
indicating comparability of gene expression between datasets collected and processed at 
the Walter Reed Army Institute of Research for US volunteers and at the Johns Hopkins 
Bloomberg School of Public Health for Cameroonian subjects. 
 
TH1 immunity related gene up-regulation during  malaria 
After P. falciparum infection, many immune response-related genes of the TH1 
immunological pathway were up-regulated (Table 1). Although interferon alpha/beta was 
not detected in this study, the major transcription factor of interferon alpha/beta synthesis, 
IRF7, was up-regulated after malaria. Many interferon alpha/beta inducible genes were 
up-regulated during the early stage of malaria including:  tryptophenyl-tRNA (IFI53), 
interferon alpha inducible protein 27 (IFI27), interferon-induced protein 44 (IFI44), 
interferon-stimulated protein 15KD (G1P2), interferon regulatory factor 1 (IRF1), 2’-5’-
oligoadenylate synthetase 3 (OAS3), signal transducer and activator of transcription 1 
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(STAT1), interferon stimulated protein 35 (IFI35), Myxovirus resistance 1 (MX1), 
interferon-induced protein with tetratricopeptide repeat 4 (IFIT4), interferon-induced 
protein with tetratricopeptide repeat 1 (IFIT1), and interferon-induced protein with 
tetratricopeptide repeat 2 (IFIT2). The expression levels of the above genes were greater 
than 2-fold in early malaria, as compared to un-infection baseline. In acute febrile malaria, 
the expression levels of most of the alpha/beta interferon genes tended to decline and all 
returned to baseline levels of expression during the remission period (Table 1).  
Interferon gamma and many interferon gamma-related genes were also up-regulated after 
malaria. These observations are consistent with a model in which malaria infection 
induces primarily a TH1 type immune response. These up-regulated genes included: 
interferon gamma, interferon inducible guanylate binding protein 1 (GBP1), interferon 
inducible guanylate binding protein 2 (GBP2), Janus kinase1 (JAK1), and transporter 
with antigen processing 1 (TAP1). The expression levels of GBP1, GBP2, and TAP1 
ranged from 10.6 to 2.8 fold above baseline during early stage of malaria, and the 
expression level of GBP2 was greater than 2-fold change during acute febrile malaria. 
These interferon gamma inducible genes all returned to baseline levels of expression 
during the remission periods of the disease. The up-regulation of a number of TH1 
chemokines over the malaria disease course was also consistent with a TH1 model of 
anti-malaria immunity.  Up-regulated TH1 related chemokine genes included: CXCL10, 
CCL3, CCL3 and CCR1. The expression levels of CXCL10 (5.3 fold) was highest during 
the early phase of malaria, while CCR3, and CCL4 were higher during febrile and 
recovery stages of the disease (Table 1). 
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There were many antibody-dependent cellular cytotoxicity (ADCC) and NK cell-
related genes up-regulated after malaria. ADCC-related genes included: Fc receptors (Fc 
alpha receptor, Fc gamma receptor 3B, Fc gamma receptor 1A, and Fc gamma receptor 
3A), and ADCC signaling genes (CD3z, Fyn, DAP12, Syk, PI3K, Rac1, PAK1, 
MAP2K1, MAP2K2, and Arf6). NK cell related genes included NK cell receptor related 
genes (KLRC3and KIR3DL2), TNF superfamily ligand 10 (TRAIL), NK cell related 
transcription factors (CEBPgamma,), interleukin 15, and NK cell restricted granzyme M. 
Interleukin 15 can enhance NK cell differentiation and proliferation. ADCC is mainly 
mediated by NK cells, but it can also be mediated by macrophages. Fc receptor and 
ADCC signaling gene up-regulation is consistent with the ADCC machinery being turned 
on after P. falciparum infection. Among the above genes, gene expression levels were 
greater than 2-fold change (range 2 to 7 fold; see Table 1) in early malaria including: Fc 
gamma receptor 1A, Fc gamma receptor 3A, Fc epsilon receptor 1G, and TRAIL. Gene 
expression levels were greater than 2-fold change in acute febrile malaria including: Fc 
alpha receptor, Fc gamma receptor 3B, Fc epsilon receptor 1G, PI3K, MAP2K2, Arf6, 
KLRC3, KIR3DL2, and CEBP gamma (range 2-4 fold). Gene expression levels were 
greater than 2-fold change in the remission period, including: Fc gamma receptor 3B, Fc 
epsilon receptor 1G, PI3K, Arf6, KLRC3, and KIR3DL2 range 2-3 fold). Although 
ADCC signaling genes were not greater than 2-fold, they were higher than 1.5-fold 
change after malarial infection. 
 
CTL related genes (CD8 T cells in Table 1) were only moderately up-regulated, 
during malaria  Among these genes, granzyme B, CDC42, and Kras exhibited  ≥  2-fold 
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change during acute febrile malaria. Granzyme B and Kras were > 2-fold change in the 
remission period. 
 
Although macrophage/monocyte activation is traditionally considered to be a 
strong marker for classic TH1 type immunity, we surprisingly found that express levels 
of most macrophage activation genes were relatively unchanged or slightly suppressed 
after P. falciparum infection (Table 2). These data support the hypothesis that there may 
be two pathways involved in the induction of TH1 types of immune responses: a TH 
interferon driven path and IL-12 driven path. (See Discussion Section). Most macrophage 
activation and proliferation related genes were un-changed. (Table 2) IL-12 is clearly the 
major cytokine needed to initiate a strong classic TH1 type immune response,  and IL-12 
expression levels remain unchanged over the course of this study (Table 2).  This 
observation suggests that the induction of a TH1-type antimalarial immune response may 
be driven by cytokines other than IL-12.  Like IL-12, other traditional TH1 cytokine: IL-3, 
M-CSF, and GM-CSF can also cause macrophage proliferation but these gene are also 
not up-regulated in response to infection with P. falciparum (Table2). In contrast, many 
macrophage inhibition-related genes were up-regulated after malaria including heme 
oxygenase 1 (HMOX1), JunB, and IRF1. JunB, PU.1 and IRF1 suppress macrophage 
proliferation. As indicated above, a macrophage differentiation inducer, MafB, is up-
regulated after malaria. Its antagonists, JunB and PU.1, were also up-regulated, so the 
effect of MafB could be suppressed. PU.1 up-regulation can drive monocytes to 
differentiate into dendritic cells instead of macrophages. Although macrophages can also 
express Fc receptor genes, we think these Fc receptor expression after malaria should 
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mainly occur in NK cells. The Fc receptor signaling pathway (ADCC signaling pathway) 
in NK cell was all up-regulated (Table 1 ). Also, DAP12 up-regulation can suppress Fc 
receptor signaling in macrophages, so it is less likely that these up-regulated Fc receptors 
belong to macrophages. Although IL-10 itself was not up-regulated, many IL-10 
downstream genes were up-regulated (Figure 1). IL-10 can activate NK cells and de-
activate macrophages. HMOX1 is the major downstream effector molecule to mediate 
IL-10 inhibition of macrophages. HMOX1 was up-regulated after malaria. HMOX1 
generates CO molecule to mediate anti-inflammatory effects in macrophages, which is 
opposite to iNOS, which generates NO molecule to cause inflammatory effects. 
Argininesuccinate synthetase (ASS) is the rate-limiting enzyme to synthesize arginine; 
the substrate of iNOS. iNOS is the central mediator representing macrophage classical 
activation; and un-changed ASS and iNOS express levels support the notion that 
macrophages are not being activated after malaria infection. In our study, macrophages 
were inhibited rather than activated after malaria. In summary, many elements of TH1 
immunity were up-regulated following infection with P. falciparum, including: interferon 
alpha/beta inducible genes, interferon gamma inducible genes, NK cell related genes (NK 
cell cytotoxicity), ADCC related genes, TH1 chemokines, and CD8 T cell related genes. 
However, macrophages appear to become deactivated and do not appear to proliferate 
after malarial infection. 
 
TH17 immunity related gene up-regulation during  malaria 
A number of genes associated with the new described TH17 immunity pathway 
were up-regulated after infection with P. falciparum (see Table 3). Of these genes, IL-8 
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showed the greatest degree of up-regulation over the entire course of the disease cycle 
(early, febrile period and remission periods), with expression levels peaking during the 
febrile period of illness (8.5 fold increase; see Table 3). Other up-regulated genes 
included other TH17 related cytokines, IL1, TGF1, and oncostatin M [OSM], as well 
as TH17 related transcription factors, CEBP delta, and CEBP gamma. In addition, 
selected neutrophil-related genes were also up-regulated, including: neutrophil attracting 
chemokines, S100A9, CXCL2, and CXCL3, the neuterophil-related CD molecules, 
ICAM1, the NADPH oxidases gene NCF1, and acute reaction protein, PGE synthetase2. 
Many complement related genes were also up-regulated including C3A receptor1, C5 
receptor1, Delay-accelerating factor (DAF), and Factor D.  
 
TH2 immunity related genes unchanged during  malaria 
Most TH2 immunity related genes were remarkably unchanged over the course of 
the malaria disease cycle (Table 4). An extensive analysis of TH2 cytokines and  
chemokines, as well as Mast cell and eosinophil genes revealed that gene expression level 
were essentially unaffected by infection with P. falciparum; thus providing strong 
evidence that TH2-type immunity was not significantly initiated during malaria in this 
study.  Expression levels for only a single gene involved in Mast cell activation, Fc 
epsilon receptor 1A surface receptor, was modified during the malaria disease cycle.  
This gene was down-regulated during early malaria and mildly up-regulated during 
remission period.  
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Gene-to-gene relationship  
We performed Pearson’s correlation to analyze gene-to-gene relationship after 
malaria infection and found a number of relationships in our study subjects that were 
consistent with observations by other investigators in previous studies. We observed a 
strong negative Pearson’s correlation between the expression levels of STAT1 and 
STAT4 in early malaria infection and acute febrile malaria (Figure 2, Panel A). There are 
positive Pearson’s correlations between the expression level of STAT1 and Fc 
receptors(ADCC related genes), but negative correlations between STAT4 and Fc 
receptors. These observations suggested that STAT1 up-regulated Fc receptors. There is 
negative correlation between STAT1 and STAT4. Although some previous studies found 
that STAT4, IL-12R, and Fc receptors are co-expressed,  STAT4 is not correlated or even 
negatively correlated with these up-regulated Fc receptors in malarial infection. Fc 
receptors suppressed STAT4 expression or STAT4 suppressed Fc receptors(Table 5). 
Rank correlation has also been done, but there were no significant results. Rank 
correlation is more strict than Pearson’s correlation. If the data is normally distributed, 
Pearson’s correlation analysis is more suitable than Rank correlation analysis.  
 
Immunological pathways  
Pathway analysis was conducted to explore immunological genetic circuitry 
during malaria infection. We selected IL-4, IL-12, TGFB1/IL-6, IL-17, IFN-/ as the 
central gene markers to explore possible networking among the 2894 genes under 
analysis in this study. We were able to identify only a few up-regulated genes in this 
cluster that centered on IL-4(Figure3-B) or IL-12 (Figure 3-C).  In contrast, gene 
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networks centered on TGFB1/IL6, IL-17 (Figure 3-D), or IFN- (Figure 3-A) were 
more dramatically altered during the malaria disease cycle. These results further support 
a model for malaria immunity, in which, IL-17/IFN-alpha/beta play a more central 
regulatory role than IL-4 and IL-12. Figure 4 shows a sketch of the major pathways of 
host immunity that are felt to play a role in recovery from malaria based on the 
observations made in this study, as well as those made by other investigators in previous 
research.  The changes in their expression levels during the early, acute, and remission 
stages of P. falciparum infection are summarized in Figure 4. As shown in Figure 5, the 
expression of genes related to TH2 immunity were unchanged following malaria 
infection; with most changes occurred in genes related to the TH17 and TH driven 
pathway of anti-malaria immunity.  
 
Validation by plasma and PBMC protein expression 
 
In our previous analysis, we have found out the concordance between transcription of 
genes and translation of proteins in malarial infection. We demonstrated the similar up-
regulation of ICAM1 level after malarial infection between microarray RNA result and 
surface protein expression detected by flowcytometry. CXCL10, CXCL9, and CCL2 
chemokine expressions are up-regulated in our microarray finding. The above chemokine 
proteins are also identified in plasma samples after malarial infection. These results show 
that our microarray analysis is validated. (Figure 1) 
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Discussion 
In previous work, we showed that Toll-like receptor signaling genes, NFkB, TNF-
alpha, IFN gamma, IL-1 beta, p38 MAPK, and MHC I & II genes were significantly up-
regulated in acute febrile malaria in comparison with un-infected baseline 10. In this 
current analysis, we identified more immunology genes, whose expression levels were 
significantly changed at different time-points over the course of the malaria disease cycle. 
Based on these results, a clearer molecular picture of the range of host immune responses 
that develop following P. falciparum has started to emerge, which suggests that the THαβ 
variant pathway of original TH1 immunity and TH17 pathway may predominate over the 
more traditional IL-12 driven TH1 immunity pathway.  However, it is important to 
remain somewhat cautions in the interpretation of the results since the health status of the 
patients from Cameroon and their genetic background are likely to be different from 
those of US volunteers. It is also important to know that PBMCs being analyzed are mix 
cell populations. Sub-populations of cell of PBMC preparation include cells, CD4 T cells, 
CD8 T cells, NK cells, and monocytes.  This cellular heterogeneity could have significant 
impact on the gene expression profiles seen after malaria infection. Because the RNA-
later reagent used to prevent RNA degradation in the PBMC preparation process , 
interferes with the surface markers of PBMCs, we were not able  to carry out cell flow 
cytometry to isolate individual cell fractions for analysis. Consequently, further studies 
are needed to know the gene expression profiles of individual lymphoid cell populations 
after acute malaria infection.  Hopefully the data presented in this thesis will help to 
direct this future research. 
 .  
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.5
93
0.
1 
: P
os
te
d 
27
 A
pr
 2
01
1
 17
Basically, host immune response can be categorized into TH1, TH2, and TH17 
immune response pathways. TH1 immune responses (Type 1 immunity) are IFN-γ and 
IgG mediated and they play an important role in host responses to viruses and 
intracellular bacteria/protozoa, TH2 immune responses are IL-4 and IgE mediated 
immunity that are important to host responses to helminthes, and TH17, initiated by 
TGF-, IL-6 and IL-17 and they are important in host responses to extracellular bacterial 
pathogens 1-2,12. In this research, our data suggests that there should be a new 
immunological pathway derived from the original TH1 immune response: TH.  THαβ 
is named after IFNα/β. In this model, THαβ is triggered by interferon alpha/beta +IL-10 
and TH1 is triggered by interleukin 12. Based on previous work by others, TH is 
important in host immunity against virus infection; TH1 is important in host immunity 
against intracellular bacteria/protozoa. Different types of host immunity have different 
effector cells. In TH2 immunity, the effector cells are mast cells, eosinophils, basophils, 
IgE/IgG4 secreting B cells, and IL-4 secreting CD4 T cells. In TH17 immunity, the 
effector cells are neutrophils, IgA/IgM/IgG2 secreting B cells, and IL-17 secreting CD4 
T cells. In TH immunity, the effector cells are NK cells, IgG1 secreting B cells, CTL, 
and IL-10(+++)/IFN-(+) secreting CD4 T cells. In TH1 immunity, the effector cells are 
macrophages, IgG3 secreting B cells, CTL, and IFN-(+++) secreting CD4 T cells. 
Similarly different types of host immunity use different STAT proteins to initiate specific 
immune reactions. IL-4 activates STAT6 in TH2 immunity. TGF- and IL-6 activates 
STAT3 in TH17 immunity. Interferon alpha/beta and IL-10 activates STAT1 and 
STAT3α in TH immunity. IL-12 activates STAT4 in TH1 immunity 13. TGF-β and IL-
2 activate STAT5 in Treg immunity. Based on our data, malaria infection appears to 
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induce a  mixed TH17 and TH immune responses which best fits with a model in 
which both pathways are activated during the onset and recovery from malaria infection.  
 
Others have shown that TGF-β with IL-6 can induce TH17 immunity 2,12. TH17 
lymphocytes also produce large amounts of IL-8, TNF-α and IL-1 which recruit and 
activate neutrophils. Due to our previous analysis, Toll-like receptor 1,2,4,7,8 are up-
regulated after malarial infection. TLR1/2/4 mainly induce anti-extracellular bacteria 
TH17 immunity. TLR7/8 binding to single strand RNA mainly induce ant-virus THαβ 
immunity. In addition, we found a lot of heat shock proteins are up-regulated after 
malarial infection. Heat shock proteins, mainly HSP60 or HSP70, can activate TLR2/4 
for inducing TH17 immunity. In this study, TGF-β, IL-1, and IL-8 were strongly up-
regulated in acute malaria (Table 3). Although IL-17 was not up-regulated, the IL-6-
related cytokine family gene-Oncostatin M was up-regulated in acute malaria infection. 
Oncostatin M can up-regulate STAT3, a key mediator in TH17 immunity 14. Thus, it 
appears that TH17 immunity can be induced in malaria infection. Up-regulated TGF-, 
IL-6, or TNF are associated with a higher frequency of malaria complications and an 
overall poor malaria prognosis. A previous study revealed that neutrophil-related genes 
were up-regulated in children after acute P. falciparum malaria infection 15. They also 
reported up-regulation of IL-6 receptor, C3AR1, C5R1, FPRL1, PBEF, and IL-1 which 
are important components of TH17 immunity. Neutrophilia has been observed in 
falciparum malaria, and elevated WBC counts are associated with severe malaria 16. Gene 
network analysis of TGFB1/IL-6 or IL-17 related gene expression after malaria infection 
also suggested that malaria was TH17 dependent. Falciparum malaria often causes 
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complications such as acute renal failure and acute respiratory distress syndrome (ARDS). 
Neutrophil overactivation in TH17 immunity is thought to play major role in the 
pathogenesis of cerebral malaria, acute renal failure, and ARDS 17-19. Thus, malaria 
induced TH17 immunity could be related to both malaria-induced cerebral malaria, acute 
renal failure, and ARDS.  
 
Evidence for dividing the more traditional TH1 immunity pathway into two 
subtypes (THαβ and TH1 immunity) comes primarily from both mouse and human 
models of malaria immunity. The major difference separating TH1 immunity and TH 
immunity are the effector cells involved. In the mouse model, interferon alpha/beta 
suppresses macrophage proliferation and neutrophiles and NK cells play a more 
prominent role, in contrast, IL-12 enhances macrophage proliferation 20-21. In addition, 
interferon alpha/beta increases NK cell blastogenesis, so alpha/beta interferon enhances 
NK cell proliferation 22. Thus, interferon alpha/beta and IL-12 mediated immunological 
events can be distinguished by the different effector cells they enhance, NK cells or 
macrophages.  
 
Both IL-12 and interferon alpha/beta can induce CD4 T cells to secret interferon 
gamma. Interferon alpha/beta can induce CD4 T cells to produce both interferon 
gamma(+) and IL-10(+++). These interferon gamma and IL-10 secreting CD4 T cells 
were previously called a type 1 regulatory T cells because IL-10 has some anti-
inflammatory effect. However, if these types of T cells are purely immuno-regulator cells, 
it cannot explain why there is interferon gamma production from these CD4 T cells. IL-
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10 is not a pure immunosuppressant because it can stimulate NK cells, B cells and CTLs. 
In fact, the regulatory effect of these Tr1 cells could be due to cross-regulation between 
Tr1 cells and other T helper cells such as TH1, TH2, and TH17 cells. In a prior mouse 
study, interferon alpha/beta can substitute for IL-12 in the induction of interferon gamma 
production associated with the development of TH1 immunity 23. In mice, interferon 
alpha/beta can also induce B cell isotype switching to produce IgG antibody 24. IL-10 can 
stimulate B cell to produce IgG1 antibody and IFNg can stimulate B cells to produce 
IgG3 antibody. Interferon alpha/beta can also cause cross-priming of CD8 T cells 25. Both 
interferon alpha/beta and IL-12 can serve as a third signal to facilitate clonal expansion of 
antigen specific CD8 T cells 26. Again in mice, interferon alpha/beta can suppress the 
proliferation of IL-17 secreting CD4 T cells 2. These observations in mice strongly 
suggest that interferon alpha/beta can induce an alternative TH1 immunity without the 
need of IL-12. In addition, interferon alpha/beta suppresses the induction of nitric oxide 
synthetase (iNOS) 27. iNOS is the central effector molecule involved in the killing of 
ingested bacteria and parasites by macrophages. Activation of iNOS is a basic tenet of 
classic macrophage activation. iNOS activation has been shown to enhance the 
intracellular killing capability of macrophages by a 1000-fold 28. iNOS can also be 
induced by interferon gamma through IL-12 mediated up-regulation. IL-10 can also serve 
as a strong macrophage de-activator. It can suppress macrophage proliferation, iNOS 
activation, and macrophage cytokine production. It can also suppress IL-12 production. 
Thus, interferon alpha/beta and IL-12 should be seen as belonging to different inductive 
immunological pathways.  
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Mouse models of anti-malaria immunity indicate that interferon gamma and TH1 
immunity play central roles in the developmental process 5. Although administration of 
IL-12 can provide 100% protection against malaria parasite challenge, IL-12 plays a 
limited role in natural immunity against malaria in mice 4. Active immunosuppression is 
well documented during malaria infection in mice 6. IL-12 expression is down relegated 
in this model 29. According to an IRF1 knockout study, mice can initiate TH1 immunity 
by bypassing the need for IL-12 production through the use of an alternate interferon 
alpha/beta driven pathway 30.  Based on recent microarray studies in malaria infected 
mice there is no evidence of IL-12 up-regulation following infection. Instead, interferon 
alpha/beta and its related genes were found to be significantly up-regulated 31-32. Thus, 
providing further evidence at the gene level that interferon alpha/beta can substitute for 
IL-12 in the induction of malaria-specific interferon gamma TH1 type immune response 
after infection in rodents. However, the IFNαβ driven THαβ immunity only can produce 
mid-to-moderate IFNg, and IL-10, the main effector molecule in THαβ immunity, 
antagonizes the effect of IFNg upon macrophages. Because the ideal traditional TH1 
immunity cannot be triggered in natural malarial infection in human to clear out the 
protozoa, malaria parasites can cause severe illness in human.  
 
In human, there is also a substantial amount of evidence indicating that TH1 
immunity can be induced by two pathways driven by αβ interferon or IL-12  33. 
Administration of IL-12 to human subjects suppresses NK cell proliferation 34. 
Macrophage activation serves to inhibit NK cell function; while NK cell activation serves 
to inhibit macrophage proliferation 20,35. Given these observation it is reasonable to 
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speculate that these two effector cells belong to different immunological pathways.In the 
present study, we found that a number of genes involved in the NK cell proliferation were 
up-regulated over the course of the malaria disease cycle  (Table 1). In addition, as in the 
mouse model, genes associated with macrophage proliferation were not up-regulated 
following infection with P. falciparum. Increased NK cell populations have also been 
reported previously in acute malaria infection 36-37. Thus, it appears that the interferon 
alpha/beta-NK cell pathway of THαβ immunity is preferentially enhanced after P. 
falciparum infection; while the IL-12 driven pathway appears unaffected. Other TH 
related cytokines also can cause NK cell activation or proliferation including IL-10 and 
IL-15, respectively. 
 
In human, interferon alpha/beta has been shown to enhance NK cell cytotoxicity 
as well as antibody dependent cell cytotoxicity (ADCC) 38, but IL-12 administration 
suppresses NK cell cytotoxicity and ADCC 39. In addition, IL-12 induces NK cell to 
secret high levels of interferon gamma to activate macrophages instead of activating NK 
cell’s cytotoxicity machinary 22. In the current study, Fc receptors, alpha/beta interferon 
and ADCC related genes were up-regulated after malaria infection. Consistent with this 
model, patients with defects in NK cell production usually suffering from recurrent virus 
infections and have more complications following malaria infection 40 41.  
 
Further evidence that interferon alpha/beta can trigger TH1 immunity without the 
need for IL-12 comes from other human studies, in which, interferon alpha/beta 
suppressed STAT6 expression which is related to IL-4 induction and expression of TH2 
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immunity 42. In our study interferon alpha/beta inducible genes were clearly up-regulated 
to induce THαβ immunity with ADCC; while TH2 related gene expression remained 
unchanged. In human models, interferon alpha/beta inhibits IL-12 production via an IL-
10 dependent mechanism43. Thus, it seems reasonable to speculate that IL-12 and 
interferon alpha/beta do not belong to the same immunological pathway. 
 
In human malarial infection, it has been shown that serum IL-12 levels are 
inversely correlated with malaria parasitemia 9. The more severe the malaria is, the lower 
IL-12 expression levels become. The up-take of malarial pigment (Hemozoin) can down-
regulate IL-12 secretion in human monocytes 8. Malarial PGE2-like molecules can also 
down-regulate IL-12 secretion 44. Up-regulation of CD36 by malarial infection can inhibit 
dendritic cell maturation with decreasing IL-12/IL-10 ratio 7. Although hemozoin, in 
certain studies, can activate TLR9 which is for traditional TH1 immunity, TLR9 is not 
detected in our study. In previous microarray analysis of human malarial infection, 
interferon inducible genes were up-regulated with un-changed IL-12 expression 15,45. 
Other important components of TH immunity included up-regulation of HMOX1, 
FAS, BCL6, TNFRSF10A, and MIP1 were noted in Griffiths’research which studied 
the peripheral blood leukocytes from Kenyan children with acute falciparum malaria. In 
this microarray study, we found up-regulation of interferon alpha/beta, interferon gamma, 
NK cell activating receptors, Fas, TRAIL, Fc gamma receptors, ADCC related genes, IL-
15, granzymes, and TH1 related chemokines (IP10, CXCL9, CXCL11, CCL3, CCL4, 
CCR1). These observations are, in general, consistent with the development of THαβ 
immunity characterized by NK cell activation induced by alpha/beta interferon following 
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P. falciparum infection. Genes associated with TH1 immunity driven by IL-12 and 
macrophage activation (iNOS up-regulation) were un-changed after malarial infection. In 
fact, genes coding for a number of  macrophage deactivation molecules were up-
regulated including TGFβ receptor, CD36, CD163-Heme oxygenase1, and CD47-SIRPα. 
These molecules can actively suppress macrophage activation. When given alone and 
prior to malaria infection IL-12 can provide 100% protection against experimental 
Plasmodium infection through the activation of macrophages, which help to control the 
liver stage of infection 4. However, based on the data collected during the course of the 
current study it also appears that infected individuals defend malaria through an alternate 
THαβ immunity, involving alpha/beta interferon and the activation of NK cells. 
Interferon gamma plays a central role in immunity against malaria. However, the natural 
host immunity is suboptimal because IFNg is not the main effector in THαβ immunity. 
The major effector cells of THαβ immunity are NK cells, and the major effector cells of 
traditional TH1 immunity are macrophages. NK cells kill virus-infected cells via ADCC 
machinery. During NK ADCC, granzyme released from NK cells into target cells will 
initiate cell apoptosis process. During this cellular apoptosis, DNA and RNA 
fragmentation will occur to chop out all the integrated form virus DNAs or latent form 
virus DNAs/RNAs by activated DNase/RNase  in host genome. Thus, virus will be killed 
via this NK cell ADCC. Malaria protozoa live in RBCs which are mainly digested by 
macrophages. Intracellular protozoa and bacteria are mainly destroyed by phagolysosome 
with iNOS, H2O2, and lysozyme activation inside macrophages. It is worth noting that 
interferon gamma significantly up-regulates macrophage phagocytosis ability. Thus, 
macrophage activation and phagocytosis is key in the host defense against intracellular 
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bacteria/protozoa infection.  That is why traditional TH1 immunity is the ideal and most 
effective immunity against malarial protozoa. 
Although IL-10, a strong macrophage de-activator, was not up-regulated in this 
study, many downstream genes of IL-10 were up-regulated including heme oxygenase 1, 
and it suggests that IL-10 is actually up-regulated after malaria infection. In an ideal 
situation, TH1 immunity is basically immunity against intracellular bacteria/protozoa; 
THαβ immunity is basically immunity against viruses. Although, it appears that 
macrophages may not be activated in natural immunity against malaria, interferon 
gamma(+) and IL-10(+++) secreting CD4 T cells, cytotoxic CD8 T cells, IgG secreting B 
cells, and NK cells are up-regulated by interferon alpha/beta in malarial infection. In a 
clinical study in Gabon, interferon-γ and IL-10 secreting CD4 T cells were increasing and 
correspondent to the recovery of P. falciparum infection 46. Pure TH1 interferon-γ 
producing T cells and pure TH2 IL-4 producing T cells were not changed during 
convalescence after malaria infection. Thus observation is consistent  with a model, in 
which, interferon-γ and IL-10 secreting T cells play important roles in host immunity 
against malaria. In conclusion, it appears that the human immune response to P. 
falciparum is characterized by a suboptimal THα/β and TH17 bias which predominates 
over the more ideal and effective traditional TH1 responses driven by IL-12. Since 
treatment for malarial infection faces some difficulty like drug resistance, we strongly 
encourage to use IFNg(FDA approval drug) or IL-12 for malarial infection treatment to 
achieve the optimal host immunity to kill the intracellular protozoa. 
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Table 1. TH1 (primarily THαβ)  immunity related gene up-regulation after malaria  
U E E/U A A/U R R/U Gene 
TH1 
Immunity 
0.595 3.656 6.1445378 1.213 2.0386555 1.003 1.6857143 IFI53 IFNa/b 
0.898 3.089 3.4398664 1.298 1.4454343 1.132 1.2605791 IFI27  
0.825 2.375 2.8787879 1.077 1.3054545 0.928 1.1248485 IFI44  
0.552 2.093 3.7916667 1.158 2.0978261 0.933 1.6902174 G1P2  
0.51 2.07 4.0588235 1.031 2.0215686 0.947 1.8568627 IRF1  
0.813 1.763 2.1685117 1.08 1.3284133 0.926 1.1389914 OAS3  
0.579 1.829 3.1588946 1.058 1.8272884 0.977 1.6873921 STAT1  
0.722 1.773 2.4556787 1.091 1.5110803 0.952 1.3185596 IFI35  
0.881 1.586 1.800227 1.069 1.2133939 0.898 1.0192963 OASL  
0.672 1.498 2.2291667 1.046 1.5565476 0.954 1.4196429 MX1  
0.662 1.532 2.3141994 1.26 1.9033233 1.097 1.6570997 IRF7  
0.898 4.549 5.0657016 0.992 1.1046771 0.894 0.9955457 IFIT4  
0.902 2.352 2.6075388 0.938 1.0399113 0.924 1.0243902 IFIT1  
0.931 1.935 2.0784103 1.065 1.1439313 0.964 1.0354458 IFIT2  
0.629 1.214 1.9300477 1.149 1.8267091 1.019 1.6200318 IFITM1  
0.655 1.043 1.5923664 2.424 3.7007634 1.694 2.5862595 IFNG IFNg 
0.587 6.22 10.596252 1.099 1.8722317 0.823 1.4020443 GBP1  
0.527 1.908 3.6204934 1.111 2.1081594 0.947 1.7969639 GBP2  
0.755 1.273 1.6860927 1.182 1.5655629 0.951 1.2596026 IFNGR2  
0.658 1.31 1.9908815 1.284 1.9513678 0.916 1.3920973 IFI30  
0.781 1.333 1.7067862 1.322 1.6927017 1.123 1.4379001 JAK2  
0.72 2.049 2.8458333 0.991 1.3763889 0.95 1.3194444 TAP1  
0.781 1.371 1.7554417 1.057 1.3533931 1.067 1.3661972 JAK1  
0.838 1.261 1.5047733 1.106 1.3198091 0.9 1.0739857 FcGR2B ADCC 
0.863 1.199 1.3893395 1.925 2.230591 1.075 1.2456547 FcAR  
0.514 0.911 1.7723735 1.658 3.2256809 1.339 2.6050584 FcGR3B  
0.708 1.208 1.7062147 1.132 1.5988701 0.896 1.2655367 FcGR2A  
0.64 4.954 7.740625 1.265 1.9765625 0.849 1.3265625 FcGR1A  
0.751 1.285 1.7110519 1.412 1.8801598 1.035 1.3781625 C1QA  
0.765 1.601 2.0928105 1.073 1.4026144 0.946 1.2366013 FcGR3A  
0.597 1.237 2.0720268 1.658 2.7772194 1.339 2.2428811 FcER1G  
0.953 0.658 0.6904512 1.298 1.3620147 1.502 1.5760756 CD3z  
0.819 0.676 0.8253968 1.455 1.7765568 1.329 1.6227106 Fyn  
0.656 1.029 1.5685976 1.219 1.8582317 1.035 1.5777439 DAP12  
0.848 0.985 1.1615566 1.271 1.4988208 1.204 1.4198113 Syk  
0.566 0.449 0.7932862 2.044 3.6113074 1.829 3.2314488 PI3K  
0.748 1.108 1.4812834 1.152 1.540107 1.03 1.3770053 Rac1  
0.83 1.21 1.4578313 1.25 1.5060241 1.13 1.3614458 PAK1  
0.823 0.807 0.9805589 1.464 1.7788578 1.191 1.4471446 MAP2K1  
0.721 0.872 1.2094313 1.516 2.1026352 1.375 1.9070735 MAP2K2  
0.644 0.81 1.257764 1.547 2.4021739 1.382 2.1459627 Arf6  
0.881 0.642 0.7287174 2.723 3.0908059 2.931 3.3269012 KLRC3 NK cell 
0.829 0.868 1.0470446 1.26 1.5199035 1.492 1.7997587 NKEFB  
0.927 0.848 0.9147789 1.442 1.5555556 1.432 1.5447681 KIR2DL3  
0.857 0.694 0.8098016 2.199 2.5659277 2.1 2.4504084 KIR3DL2  
0.77 3.235 4.2012987 0.835 1.0844156 0.798 1.0363636 TNFSF10  
0.653 1.242 1.9019908 1.152 1.7641654 1 1.5313936 Fas  
0.693 0.991 1.4300144 1.144 1.6507937 1.084 1.5642136 MICB  
0.901 0.772 0.8568257 1.439 1.5971143 1.31 1.4539401 ETS1  
0.704 0.899 1.2769886 1.596 2.2670455 1.379 1.9588068 CEBPg  
0.757 1.145 1.5125495 1.119 1.4782034 1.02 1.347424 MEF  
0.638 0.765 1.1990596 1.674 2.6238245 1.458 2.2852665 ID2  
0.71 1.397 1.9676056 1.092 1.5380282 0.884 1.2450704 IL15  
0.908 0.738 0.8127753 1.521 1.6751101 1.626 1.7907489 GZMM  
0.768 0.962 1.2526042 1.568 2.0416667 1.199 1.5611979 CD58  
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0.548 1.223 2.2317518 1.491 2.7208029 0.963 1.7572993 CCR1 
TH1 
Chemokine 
0.381 0.974 2.5564304 2.085 5.4724409 1.713 4.496063 CCL3  
0.689 0.735 1.0667634 3.206 4.6531205 2.65 3.8461538 CCL4  
0.986 5.194 5.2677485 1.045 1.0598377 0.956 0.969574 CXCL10  
1.029 1.576 1.5315841 0.835 0.8114674 0.83 0.8066084 CXCL9  
0.824 1.265 1.5351942 0.924 1.1213592 0.808 0.9805825 CXCL11  
0.863 0.641 0.7427578 1.495 1.7323291 1.557 1.8041715 GZMK CD8 T cell 
0.795 0.651 0.8188679 1.98 2.490566 1.739 2.1874214 GZMB  
0.881 0.638 0.7241771 1.236 1.4029512 1.522 1.7275823 GZMA  
0.829 0.765 0.9227986 1.432 1.7273824 1.385 1.6706876 RUNX3  
0.656 1.07 1.6310976 1.308 1.9939024 1.106 1.6859756 Rel  
0.925 0.812 0.8778378 1.497 1.6183784 1.593 1.7221622 CD3g  
0.871 0.892 1.0241102 2.021 2.3203215 1.719 1.9735936 CDC42  
0.749 0.692 0.9238985 1.885 2.5166889 1.524 2.034713 Kras  
0.78 1.159 1.4858974 1.209 1.55 1.094 1.4025641 ICOS  
0.784 0.915 1.1670918 1.497 1.9094388 1.486 1.8954082 CD28  
0.77 1.007 1.3077922 1.224 1.5896104 1.038 1.3480519 Bcl10  
0.816 0.87 1.0661765 1.557 1.9080882 1.45 1.7769608 MALT1  
Table 2. TH1 (primary TH12) immunity un-changed after malaria 
0.755 1.273 1.6860927 1.182 1.5655629 0.951 1.2596026 IFNGR2 
Macrophag
e 
1.02 0.91 0.8921569 1.16 1.1372549 1.13 1.1078431 CD40L Activation 
0.804 1.271 1.5808458 1.132 1.4079602 1.098 1.3656716 TNFalpha  
0.97 1.04 1.0721649 1.01 1.0412371 1.03 1.0618557 TNFbeta  
0.733 1.263 1.7230559 1.293 1.7639836 0.864 1.1787176 TLR2  
0.744 1.125 1.5120968 1.385 1.8615591 0.991 1.3319892 TLR4  
0.739 1.051 1.4221922 1.408 1.9052774 1.044 1.4127199 TLR8  
0.99 1.04 1.0505051 1.03 1.040404 1 1.010101 IL12A  
1.02 1.04 1.0196078 0.96 0.9411765 0.95 0.9313725 IL12B  
1.13 1.08 0.9557522 0.96 0.8495575 0.94 0.8318584 IL12RB1  
1.04 1.16 1.1153846 1.02 0.9807692 0.97 0.9326923 IL12RB2  
1.04 0.78 0.75 1.22 1.1730769 1.27 1.2211538 STAT4  
1.03 1.08 1.0485437 1.02 0.9902913 1.01 0.9805825 iNOS  
1.054 1 0.9487666 1 0.9487666 1.04 0.9867173 ASS  
1 1.27 1.27 0.94 0.94 0.96 0.96 MMP9  
0.87 0.98 1.1264368 1.19 1.3678161 1.12 1.2873563 TRAF6  
0.98 1.03 1.0510204 0.99 1.0102041 1 1.0204082 TRANCE  
1.05 1.06 1.0095238 0.94 0.8952381 0.94 0.8952381 RANK  
0.99 1.039 1.0494949 0.97 0.979798 0.99 1 ERM  
1.07 1.08 1.0093458 0.93 0.8691589 0.92 0.8598131 M-CSF 
Macrophag
e 
1.02 1.03 1.0098039 0.97 0.9509804 0.97 0.9509804 GM-CSF Proliferation 
1.11 1.03 0.9279279 0.94 0.8468468 0.89 0.8018018 IL-3  
0.92 1.04 1.1304348 1.13 1.2282609 1.04 1.1304348 RUNX1  
0.86 0.89 1.0348837 0.85 0.9883721 0.84 0.9767442 Myb  
1.21 1.25 1.0330579 0.81 0.6694215 0.87 0.7190083 Myc  
1 1.24 1.24 1 1 0.95 0.95 CEBPalpha  
1.04 1.04 1 1 0.9615385 1.03 0.9903846 HOXB7  
1.06 1.17 1.1037736 0.95 0.8962264 0.97 0.9150943 GATA1  
1.07 1.06 0.9906542 0.95 0.8878505 0.98 0.9158879 GATA2  
1.12 1.19 1.0625 0.82 0.7321429 0.86 0.7678571 Tal1  
0.358 0.952 2.6592179 2.495 6.9692737 1.351 3.773743 MafB  
0.841 0.809 0.9619501 1.401 1.665874 1.295 1.5398335 TGFBR2 
Macrophag
e 
0.85 1.355 1.5941176 1.024 1.2047059 0.727 0.8552941 CD36 Inhibition 
0.706 0.972 1.3767705 1.307 1.8512748 1.209 1.7124646 CD47  
0.943 0.783 0.8303287 1.521 1.6129374 1.097 1.1633086 CD163  
0.522 0.781 1.4961686 1.776 3.4022989 1.556 2.9808429 JunB  
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0.51 2.07 4.0588235 1.031 2.0215686 0.947 1.8568627 IRF1  
0.73 0.95 1.3013699 2.62 3.5890411 1.81 2.4794521 HMOX1  
0.83 1.24 1.4939759 1.27 1.5301205 0.97 1.1686747 SIRPalpha  
0.7 1.319 1.8842857 1.48 2.1142857 1.02 1.4571429 PU.1  
Red color means greater than 2-fold change;  
yellow color means 1.5-2-fold change;  
green color means no change 
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Table 3. TH17 related gene up-regulation after malaria 
U E E/U A A/U R R/U Gene 
TH17Immuni
ty 
0.767 0.775 1.0104302 1.275 1.6623207 1.382 1.8018253 IL32 
IL17 CD4 
Tcell 
0.343 0.779 2.271137 2.922 8.5189504 1.389 4.0495627 IL8  
0.805 1.265 1.5714286 2.276 2.8273292 1.931 2.3987578 IL1B  
0.804 1.271 1.5808458 1.132 1.4079602 1.098 1.3656716 TNFalpha  
0.653 1.019 1.56049 1.346 2.0612557 1.156 1.770291 TGFB1  
0.841 0.809 0.9619501 1.401 1.665874 1.295 1.5398335 TGFBR2  
0.795 0.907 1.1408805 1.849 2.3257862 1.491 1.8754717 OSM  
0.77 1.333 1.7311688 1.04 1.3506494 0.865 1.1233766 STAT3  
0.764 0.894 1.1701571 2.98 3.9005236 1.648 2.1570681 CEBPD  
0.459 0.991 2.1590414 1.694 3.6906318 1.163 2.5337691 CEBPB  
0.903 1.552 1.7187154 0.899 0.9955703 0.787 0.8715393 S100A8 Neutrophil 
0.707 1.568 2.2178218 1.049 1.4837341 0.852 1.2050919 S100A9  
0.667 0.97 1.4542729 2.827 4.2383808 1.699 2.5472264 CXCL2  
0.923 1.027 1.1126761 2.027 2.1960997 1.333 1.4442037 CXCL3  
0.745 1.4 1.8791946 1.182 1.5865772 0.946 1.2697987 CD63  
0.708 1.26 1.779661 1.183 1.670904 0.917 1.2951977 CD157  
0.722 1.948 2.6980609 1.155 1.599723 0.923 1.2783934 ICAM1  
0.725 0.911 1.2565517 1.167 1.6096552 1.054 1.4537931 ITGB2  
0.954 2.945 3.0870021 0.939 0.9842767 0.801 0.8396226 NCF1  
0.827 1.471 1.7787183 1.116 1.3494559 0.953 1.1523579 NCF4  
0.742 1.047 1.4110512 1.202 1.6199461 1.011 1.3625337 CD97  
0.709 1.382 1.9492243 1.16 1.6361072 0.801 1.1297602 FPR1  
0.918 1.131 1.2320261 1.619 1.7636166 1.23 1.3398693 Pentraxin3  
0.723 1.08 1.4937759 2.135 2.9529737 1.895 2.6210235 PGES2  
0.635 1.087 1.711811 2.079 3.2740157 1.218 1.9181102 C3AR1 Complement 
0.623 0.908 1.4574639 2.628 4.2182986 1.571 2.5216693 C5R1  
0.552 0.881 1.5960145 2.297 4.1612319 1.392 2.5217391 DAF  
0.751 1.285 1.7110519 1.412 1.8801598 1.035 1.3781625 C1QA  
0.67 0.914 1.3641791 1.349 2.0134328 1.166 1.7402985 FactorD  
0.761 1.093 1.4362681 1.418 1.8633377 1.121 1.4730618 Properdin  
Red color means greater than 2-fold change;  
yellow color means 1.5-2-fold change;  
green color means no change 
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Table 4. TH2 related gene un-changed after malaria 
U E E/U A A/U R R/U Gene 
TH2Immunit
y 
1.09 1.06 0.9724771 0.97 0.8899083 1.02 0.9357798 IL4 
IL4 CD4 
Tcell 
1.07 1.08 1.0093458 0.97 0.9065421 1 0.9345794 IL4R  
1.02 1.08 1.0588235 0.99 0.9705882 0.97 0.9509804 IL5  
1.06 1 0.9433962 0.98 0.9245283 0.99 0.9339623 IL5R  
1.08 1.1 1.0185185 0.95 0.8796296 0.92 0.8518519 IL9  
1.08 1.08 1 0.99 0.9166667 0.95 0.8796296 IL9R  
0.94 0.99 1.0531915 1.15 1.2234043 1.09 1.1595745 IL10  
0.93 0.85 0.9139785 1.08 1.1612903 1.17 1.2580645 IL10RA  
1.09 1.05 0.9633028 0.95 0.8715596 0.92 0.8440367 IL13  
0.98 1.14 1.1632653 1.23 1.255102 0.99 1.0102041 IL13RA1  
1.13 1.01 0.8938053 1.01 0.8938053 1.01 0.8938053 IL13RA2  
1.1 1.13 1.0272727 0.91 0.8272727 0.96 0.8727273 CCR3  
1.08 0.96 0.8888889 0.98 0.9074074 1.01 0.9351852 CCR4  
1.11 1.2 1.0810811 0.86 0.7747748 0.95 0.8558559 CCR8  
1.08 1.12 1.037037 0.89 0.8240741 0.94 0.8703704 CCL17  
0.99 1.1 1.1111111 0.91 0.9191919 0.95 0.959596 CCL22  
1.09 1.04 0.9541284 0.92 0.8440367 0.93 0.853211 CRTH2  
1.05 0.94 0.8952381 1.08 1.0285714 0.98 0.9333333 CD30  
0.92 0.98 1.0652174 1.13 1.2282609 1.17 1.2717391 OX40  
1.32 1.31 0.9924242 0.93 0.7045455 0.89 0.6742424 OX40L  
1.01 0.88 0.8712871 1.01 1 0.99 0.980198 STAT6  
1 0.92 0.92 1.18 1.18 1.16 1.16 GATA3  
0.98 1 1.0204082 0.96 0.9795918 1 1.0204082 NFATc  
0.92 0.91 0.9891304 1.27 1.3804348 1.31 1.423913 Gfi-1  
0.96 1.09 1.1354167 1.1 1.1458333 1.07 1.1145833 SPHK1  
1.05 1.02 0.9714286 0.97 0.9238095 1 0.952381 SH2D1A  
1.12 1.08 0.9642857 0.87 0.7767857 0.85 0.7589286 ST2L  
1.11 1.06 0.954955 0.94 0.8468468 0.98 0.8828829 A3AR Mast cell 
1.1 1.13 1.0272727 0.91 0.8272727 0.96 0.8727273 CCR3  
1.03 1.22 1.184466 0.89 0.8640777 0.99 0.961165 FCER2  
1.14 0.63 0.5526316 1.17 1.0263158 1.72 1.5087719 FCER1A  
1.09 1.13 1.0366972 0.93 0.853211 1.01 0.9266055 LTC4S  
0.95 0.96 1.0105263 1.11 1.1684211 1.05 1.1052632 MGST2  
0.89 0.93 1.0449438 1.19 1.3370787 1.13 1.2696629 MGST3  
0.92 0.92 1 0.84 0.9130435 0.85 0.923913 CysLTR1  
1.07 1.04 0.9719626 0.94 0.8785047 0.94 0.8785047 CysLTR2  
1.02 1.08 1.0588235 0.99 0.9705882 0.97 0.9509804 IL5 Eosinophil 
1.11 1.01 0.9099099 0.97 0.8738739 1.02 0.9189189 Eotaxin1  
1.18 1.17 0.9915254 0.88 0.7457627 0.89 0.7542373 Eotaxin2  
Red color means greater than 2-fold change;  
yellow color means 1.5-2-fold change;  
green color means no change 
blue color means down-regulation 
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Table 5. Correlation between Fc receptor/complement receptor and STAT1/STAT4 
in acute febrile malaria 
 
 Gene STAT1 STAT4 
   
FCER1G 0.9   (0.001) -0.71 (0.01) 
   
FCGR1A 0.88 (0.001) -0.74 (0.01) 
   
FCGR2A 0.79 (0.01) -0.79 (0.01) 
   
FCGR2B 0.74 (0.01) -0.77 (0.01) 
   
Fas 0.71 (0.01) -0.64 (0.05) 
   
C3AR 0.86 (0.001) -0.73 (0.01) 
   
DAF 0.64 (0.05) -0.66 (0.02) 
   
C1QA 0.71 (0.01) -0.64 (0.05) 
   
Properdin 0.82 (0.01) -0.68 (0.02) 
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Figure Legends 
 
FIG. 1. IL-10 related gene up-regulation during acute febrile malaria; Comparison of 
chemokine levels between microarray analysis and serum plasma 
 
FIG. 2. Gene-to-gene correlation. 
Panel A: negative correlation between STAT1 and STAT4,  
Pearson’s correlation coefficient (r) and its P value  (p) were calculated for each graph 
 
FIG. 3.  
 
3-A IFN-αβ centered pathway analysis. Network analysis was performed by using IFN- 
and IFN- as the central nodes. We used software to select IFN- or IFN- related genes 
from our genelist. 24 IFN- or IFN- related genes were selected. Red entities mean 
proteins. Green entities mean small molecules including phospholipids and drugs. Hexon 
means groups of family proteins. A---B means A binds to B to form a complex. A- B 
means A binds B’s promoter region to up-regulate B. A--+->B means A induces B 
release. A---|B means A causes B’s degradation or inhibition. Little square in the middle 
of the line means there is a third molecule which regulates the conversion from A to B. 
3-B IL-4 centered pathway analysis. Network analysis was performed by using IL-4 as 
the central nodes. We used software to select IL-4 related genes from our genelist. Only 4 
IL-4 related genes were selected.   
3-C IL-12 centered pathway analysis. Network analysis was performed by using IL-12 as 
the central nodes. We used software to select IL-12 related genes from our genelist. Only 
4 IL-12A/IL12B related genes were selected.   
3-D TGF-/Oncostatin M centered pathway analysis. Network analysis was performed 
by using  TGF-/Oncostatin M as the central nodes. We used software to select TGF-
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/Oncostatin M related genes from our genelist. 22 TGF-/Oncostatin M related genes 
were selected. Red entities mean s proteins. 
FIG. 4. Proposed model for the four types of host immunity.  
 
Green color means un-changed and red color means up-regulated genes after malaria 
infection. TH2 immunity is induced by STAT6 activated by IL-4. TH immunity is 
induced by STAT1 & STAT3 activated by IFN-. TH1 immunity is induced by 
STAT4 activated by IL-12. TH17 immunity is induced by STAT3 activated by TGF-
/IL-6 to induce downstream PMN related genes and proinflammatory cytokines (TNF, 
IL1, IL8). In TH immunity, IFN-/ can suppress STAT6. IFN-/ also suppress 
iNOS and IL-12 via IL-10 dependent mechanism. Up-regulated STAT1 can suppress 
GATA3 and STAT4. STAT1 can up-regulate IRF1, T-bet, IgG Fc receptors, Fas, C3a 
receptor. IRF1 induced TRAIL, T-bet induced NK cell killer receptors, and Fas can 
enhance NK cell cytotoxicity. Up-regulated IgG Fc receptors can mediate ADCC. In T 
cell, T-bet can up-regulate IFN-. Up-regulated IFN- can activate STAT1 signaling via 
IFN- receptor. However, the IFN- receptor is suppressed during lymphocyte maturation. 
Thus, TH immunity can be separated from TH1 immunity. 
FIG 5.  
 
5-A. Summary of gene expression of the four immunological pathways during the early 
malaria, acute febrile malaria, and remission period compared to un-infection baseline. 
Red color means gene expression with greater than two-fold up-regulation. Yellow color 
means gene expression with 1.5 to 2-fold up-regulation. Green color means gene 
expression was not changed. Square shape means genes which activate the cell, and 
ellipse shape means genes which suppress the cell. Although interferon alpha/beta was 
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not detected, ( IRF7) means that this up-regulated gene regulates the transcription of 
interferon alpha/beta. 
5-B. Gene expression during early malaria infection, 
5-C. Gene expression during acute febrile malaria infection,  
5-D. Gene expression during the remission period 
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FIG 1. 
 
 
 
 
 
(cited from Ockenhouse & Hu et al.(2006) Infect Immun 74(10),5561) 
 
 
 
 
 
 
 
 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.5
93
0.
1 
: P
os
te
d 
27
 A
pr
 2
01
1
 40
 
 
FIG. 2. 
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FIG. 3.  
 
 
3-A 
 
 
3-B 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.5
93
0.
1 
: P
os
te
d 
27
 A
pr
 2
01
1
 42
 
 
 
3-C 
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FIG. 4. 
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FIG. 5. 
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5-B 
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5-C 
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